Sentinel lymph node biopsy in early cervical cancer: a prospective randomized controlled study

A prospective randomized controlled study on sentinel lymph node biopsy in patients with early- stage cervical cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072405

Enrollment

Unknown

Registered

2023-06-13

Start date

2023-04-01

Completion date

Unknown

Last updated

2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

sentinel lymph node biopsy group:sentinel lymph node biopsy

pelvic lymphadenectomy group:pelvic lymphadenectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) Stage IA2-IB1 was first diagnosed according to the 2018 FIGO clinical staging criteria and no treatment was given; ? Cervical pathological biopsy was diagnosed as cervical squamous cell carcinoma or adenocarcinoma. ? Preoperative MRI and other imaging data showed no lymph node metastasis. (4) Voluntarily participated in the experiment and signed the informed consent

Exclusion criteria

Exclusion criteria: ? with severe diseases of other organs; Previous history of other malignancies; (2) Absolute contraindications for pregnancy and surgery; ? Serious mental illness; (4) Poor compliance.

Design outcomes

Primary

Measure	Time frame
Recurrence rate;	—

Secondary

Measure	Time frame
lymphatic leakage and lymphatic retention cyst;lower limb edema;Intraoperative blood loss and operative time;Postoperative pelvic drainage;Number of pathological lymph node positive cases;Number of cases of postoperative adjuvant chemoradiotherapy;Postoperative quality of life;	—

Countries

China

Contacts

Public ContactRuixia Guo

The First Affiliated Hospital of Zhengzhou University

grxcdxzzu@163.com+86 135 2556 9376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026